A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Development of Medical Technology for Contingency Response to Marrow Toxic Agents
[report]
2012
unpublished
Published research data have clearly defined the relationship between HLA matching and optimal patient outcomes following unrelated adult donor transplantation. Continually working to increase the genetic diversity of the Registry helps to ensure that more patients will be able to locate a suitably matched stem cell product for a transplant. During this time frame, NMDP donor centers (including Department of Defense (DoD)) and recruitment groups added 374,840 minority race and 407,588 Caucasian
doi:10.21236/ada565324
fatcat:aqcaxacxqfeo7hl4bgjwzwkn6e